18 in stock
Oxytocin 10 mg is a research-grade cyclic nonapeptide attracting scientific interest for its established neuroendocrine physiology and its promising influence on OXTR signalling, social cognition, stress responses and regenerative pathways.
Oxytocin is a naturally occurring peptide hormone and neuropeptide made primarily in the hypothalamus. It is released into the circulation from the posterior pituitary and is also released within the brain, where it participates in neural communication.
Its nine-amino-acid structure contains a disulfide bond that creates a six-residue ring with a short three-residue tail. The peptide binds primarily to OXTR, a G-protein-coupled receptor expressed in reproductive tissue and distributed across multiple peripheral and neural systems.
The best-established functions involve uterine contraction and milk ejection. Beyond those classical roles, Oxytocin 10 mg offers researchers a compelling way to investigate social-information processing, affiliation, stress adaptation, autonomic regulation, metabolism and tissue regeneration.
OXTR activation engages intracellular calcium and kinase signalling, giving researchers a measurable route from receptor binding to cellular response.
The peptide operates as both a circulating hormone and a locally released neural signal, connecting reproductive physiology with behavioural and autonomic research.
Encouraging studies extend into social cognition, stress, metabolism, inflammation and repair, creating a wide but still developing research landscape.
OXTR most commonly couples to Gq/11, activating phospholipase C and increasing intracellular calcium. Depending on the cell type, receptor density and surrounding signals, OXTR can also influence ERK/MAPK, nitric-oxide and other networks. This helps explain why one peptide can participate in smooth-muscle contraction, secretion, neuronal activity and tissue-response research.
| Research area | Encouraging observation | Evidence level | Important context |
|---|---|---|---|
| Reproductive physiology | OXTR signalling has clear, reproducible roles in uterine contraction and milk ejection. | Established human physiology and supervised clinical use | Approved pharmaceutical preparations and obstetric monitoring are distinct from a research vial. |
| Social cognition | Human experiments have reported changes in social attention, emotion recognition, trust-related decisions and neural responses to social cues. | Human experimental studies and meta-analyses | Results vary by task, population, sex, personal traits and social setting. |
| Stress and autonomic responses | Some studies report reduced stress reactivity, altered cortisol responses and improved positive communication under specific conditions. | Human and preclinical research | The effect is not uniformly calming and may depend on the social environment. |
| Muscle regeneration | In aged mice, systemic exposure improved muscle stem-cell activation and regenerative signalling. | Cell and animal research | Promising preclinical biology does not establish recovery or anti-aging outcomes in humans. |
| Metabolic signalling | Preclinical work suggests possible influence on appetite, energy expenditure, glucose regulation and adipose-tissue biology. | Primarily animal studies with limited early human work | No weight-loss or metabolic-treatment benefit is established for this product. |
The expanding scientific interest surrounding Oxytocin 10 mg includes several important biological systems:
The human literature contains many positive signals. Controlled experiments have reported greater attention to the eye region, changes in emotion recognition, altered amygdala activity and shifts in trust-related or cooperative decisions. These findings support a meaningful role for the oxytocin system in social-information processing.
At the same time, the peptide does not produce one universal “pro-social” response. Some experiments report no effect or effects that vary with sex, attachment style, baseline anxiety, group membership and whether a social situation feels safe or threatening.
A useful interpretation is that OXTR signalling may increase the importance or salience of social cues. In a supportive setting, that may appear as trust, connection or reduced stress. In a competitive or uncertain setting, the observed response may differ. This context-sensitive model keeps the research outlook positive while fitting the mixed human findings more accurately.
| Feature | Peripheral signalling | Central signalling |
|---|---|---|
| Primary release | Posterior pituitary into circulation | Neuronal release within the brain |
| Classical research | Uterine contraction and milk ejection | Social memory, affiliation, emotion and stress processing |
| Measurement challenge | Plasma levels are accessible but change quickly | Central levels and receptor engagement are difficult to measure directly in humans |
| Interpretation | Circulating concentration does not necessarily mirror brain concentration | Behavioural change may reflect direct central action, indirect peripheral signalling or both |
Published research uses several experimental routes. Human social-cognition studies commonly examine intranasal preparations, while established medical applications use regulated pharmaceutical formulations in closely supervised settings. Preclinical studies may use additional routes that are designed for a specific animal or cell model.
Route matters because peripheral exposure, central availability, timing and receptor engagement are not interchangeable. Researchers also continue to debate how much intranasally delivered peptide reaches the human brain directly and how much of the observed response may arise through indirect peripheral-to-central signalling.
No standardized human dose, cycle length, injection schedule or product-specific administration protocol has been established for this research product. The 10 mg designation describes the total laboratory quantity in the vial and should not be interpreted as a dose or administration instruction.
Short-term controlled studies provide useful human data, but safety and biological effects depend on route, formulation, exposure, population and research setting. The long-term effects of repeated experimental exposure remain incompletely defined.
Because OXTR participates in uterine, cardiovascular, fluid-balance and neural pathways, results from one setting should not be transferred casually to another. Approved pharmaceutical oxytocin used by medical teams for specific obstetric purposes is not equivalent to a laboratory research product.
Overall, the established physiology and promising behavioural, metabolic and regenerative findings make Oxytocin 10 mg a valuable research compound. Additional well-powered and reproducible studies are still required before emerging findings can be treated as established therapeutic outcomes.
| Research product | Primary pathway | Main distinction |
|---|---|---|
| Oxytocin 10 mg | OXTR signalling | Social-neuroendocrine, smooth-muscle and regenerative research |
| Kisspeptin-10 10 mg | KISS1R → GnRH → LH/FSH | Upstream reproductive hormone-axis research |
| PT-141 10 mg | Melanocortin receptors | Central sexual-response research rather than OXTR signalling |
| Selank 10 mg | Neurotransmitter and neurotrophic pathways | Neurobehavioural and stress-response research through a different mechanism |
These compounds investigate distinct biological pathways and should not be treated as interchangeable. Combining research compounds does not establish additive or synergistic results.
Research-use notice: Oxytocin 10 mg is presented for laboratory research and analytical discussion only. It is not intended to diagnose, treat, cure or prevent disease, or for human or animal use. This information is not medical advice or an administration guide.
